Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2025-12-24 @ 6:51 PM
NCT ID:
NCT03078257
Eligibility Criteria:
Inclusion Criteria:
1. CAD patients plan to receive coronary arteriography (CAG) or percutaneous coronary intervention (PCI).
2. Patient aged \>18 years and ≦75 years old;
3. Signed inform consent
Exclusion Criteria:
1. Allergy or intolerance to ASA, clopidogrel , tirofiban ,antiplatelet thrombolysin;
2. Subjects at a high risk of bleeding (e.g. platelet count\< 100\*109/L, known bleeding diathesis , active peptic ulcer );
3. Patients who are planning to take warfarin or drugs that potentially could interfere with the anti-platelet effects .
4. severe hemodynamic instability
5. severe liver and renal dysfunction
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT03078257
Study Brief:
Protocol Section:
NCT03078257